RHYTHM PHARMACEUTICALS, INC. Stock-Based Compensation
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Stock-Based Compensation of $49.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-04
- RHYTHM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $26.06M, a 64.08% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $23.10M, a 79.59% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $19.27M, a 82.51% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $18.81M, a 70.98% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $66.82M, a 68.38% increase from fiscal 2024.
- RHYTHM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $39.68M, a 21.90% increase from fiscal 2023.
- RHYTHM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $32.55M, a 64.15% increase from fiscal 2022.
- RHYTHM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $19.83M, a 4.68% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $49.16M 10-Q · filed 2026-08-04 | $68.42M derived: sum of 3 quarters · filed 2026-08-04 | $87.23M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $23.10M 10-Q · filed 2026-05-05 | $42.37M derived: sum of 2 quarters · filed 2026-05-05 | $61.17M derived: sum of 3 quarters · filed 2026-05-05 | $77.06M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $19.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.08M derived: sum of 2 quarters · filed 2026-02-26 | $53.96M derived: sum of 3 quarters · filed 2026-08-04 | $66.82M 10-K · filed 2026-02-26 |
| 2025-09-30 | $18.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $34.69M derived: sum of 2 quarters · filed 2026-08-04 | $47.55M 10-Q · filed 2025-11-04 | $58.11M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $15.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $28.74M 10-Q · filed 2026-08-04 | $39.30M derived: sum of 3 quarters · filed 2026-08-04 | $50.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $12.86M 10-Q · filed 2026-05-05 | $23.42M derived: sum of 2 quarters · filed 2026-05-05 | $34.42M derived: sum of 3 quarters · filed 2026-05-05 | $44.78M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $10.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $21.56M derived: sum of 2 quarters · filed 2026-02-26 | $31.91M derived: sum of 3 quarters · filed 2026-02-26 | $39.68M 10-K · filed 2026-02-26 |
| 2024-09-30 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $21.36M derived: sum of 2 quarters · filed 2025-11-04 | $29.13M 10-Q · filed 2025-11-04 | $37.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $10.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $18.13M 10-Q · filed 2025-08-05 | $26.80M derived: sum of 3 quarters · filed 2026-02-26 | $35.41M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $7.77M 10-Q · filed 2025-05-07 | $16.44M derived: sum of 2 quarters · filed 2026-02-26 | $25.05M derived: sum of 3 quarters · filed 2026-02-26 | $33.94M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $8.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $17.29M derived: sum of 2 quarters · filed 2026-02-26 | $26.18M derived: sum of 3 quarters · filed 2026-02-26 | $32.55M 10-K · filed 2026-02-26 |
| 2023-09-30 | $8.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $17.50M derived: sum of 2 quarters · filed 2024-11-06 | $23.88M 10-Q · filed 2024-11-06 | $29.17M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $8.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $15.27M 10-Q · filed 2024-08-06 | $20.55M derived: sum of 3 quarters · filed 2025-02-28 | $25.35M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $6.38M 10-Q · filed 2024-05-07 | $11.66M derived: sum of 2 quarters · filed 2025-02-28 | $16.46M derived: sum of 3 quarters · filed 2025-02-28 | $21.60M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $10.08M derived: sum of 2 quarters · filed 2025-02-28 | $15.22M derived: sum of 3 quarters · filed 2025-02-28 | $19.83M 10-K · filed 2025-02-28 |
| 2022-09-30 | $4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $9.93M derived: sum of 2 quarters · filed 2023-11-08 | $14.54M 10-Q · filed 2023-11-08 | $19.22M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $5.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $9.75M 10-Q · filed 2023-08-01 | $14.42M derived: sum of 3 quarters · filed 2024-02-29 | $19.69M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $4.61M 10-Q · filed 2023-05-02 | $9.29M derived: sum of 2 quarters · filed 2024-02-29 | $14.55M derived: sum of 3 quarters · filed 2024-02-29 | $20.22M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $9.94M derived: sum of 2 quarters · filed 2024-02-29 | $15.61M derived: sum of 3 quarters · filed 2024-02-29 | $20.80M 10-K · filed 2024-02-29 |
| 2021-09-30 | $5.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $10.94M derived: sum of 2 quarters · filed 2022-11-08 | $16.13M 10-Q · filed 2022-11-08 | $20.39M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $5.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $10.86M 10-Q · filed 2022-08-03 | $15.12M derived: sum of 3 quarters · filed 2023-03-01 | $19.81M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $5.19M 10-Q · filed 2022-05-03 | $9.45M derived: sum of 2 quarters · filed 2023-03-01 | $14.14M derived: sum of 3 quarters · filed 2023-03-01 | $17.17M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $8.95M derived: sum of 2 quarters · filed 2023-03-01 | $11.98M derived: sum of 3 quarters · filed 2023-03-01 | $17.45M 10-K · filed 2023-03-01 |
| 2020-09-30 | $4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $7.72M derived: sum of 2 quarters · filed 2021-11-02 | $13.20M 10-Q · filed 2021-11-02 | $16.12M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $8.50M 10-Q · filed 2021-08-03 | $11.43M derived: sum of 3 quarters · filed 2021-08-03 | $14.46M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $5.47M 10-Q · filed 2021-05-03 | $8.40M derived: sum of 2 quarters · filed 2021-05-03 | $11.43M derived: sum of 3 quarters · filed 2021-05-03 | $14.71M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $5.96M derived: sum of 2 quarters · filed 2021-03-01 | $9.23M derived: sum of 3 quarters · filed 2021-03-01 | $11.88M 10-K · filed 2021-03-01 |
| 2019-09-30 | $3.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $6.31M derived: sum of 2 quarters · filed 2020-11-02 | $8.95M 10-Q · filed 2020-11-02 | $10.97M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $3.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $5.92M 10-Q · filed 2020-08-03 | $7.94M derived: sum of 3 quarters · filed 2021-03-01 | $9.83M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $2.64M 10-Q · filed 2020-05-04 | $4.67M derived: sum of 2 quarters · filed 2021-03-01 | $6.56M derived: sum of 3 quarters · filed 2021-03-01 | $8.08M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.92M derived: sum of 2 quarters · filed 2021-03-01 | $5.43M derived: sum of 3 quarters · filed 2021-03-01 | $6.39M 10-K · filed 2021-03-01 |
| 2018-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $3.41M derived: sum of 2 quarters · filed 2019-11-01 | $4.37M 10-Q · filed 2019-11-01 | $5.08M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $2.47M 10-Q · filed 2019-07-29 | $3.18M derived: sum of 3 quarters · filed 2020-03-02 | $4.05M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $958.00K 10-Q · filed 2019-05-03 | $1.67M derived: sum of 2 quarters · filed 2020-03-02 | $2.54M derived: sum of 3 quarters · filed 2020-03-02 | $2.97M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $709.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.58M derived: sum of 2 quarters · filed 2020-03-02 | $2.01M derived: sum of 3 quarters · filed 2020-03-02 | $2.28M 10-K · filed 2020-03-02 |
| 2017-09-30 | $871.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.30M derived: sum of 2 quarters · filed 2018-11-09 | $1.57M 10-Q · filed 2018-11-09 | $1.88M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $434.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $698.00K 10-Q · filed 2018-08-08 | $1.01M derived: sum of 3 quarters · filed 2019-03-08 | |
| 2017-03-31 | $264.00K 10-Q · filed 2018-05-14 | $573.00K derived: sum of 2 quarters · filed 2019-03-08 | ||
| 2016-12-31 | $309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $1.17M 10-K · filed 2019-03-08 | ||
| 2016-09-30 | $859.00K 10-Q · filed 2017-11-14 | |||
| 2015-12-31 | $298.00K 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |